ClinicalTrials.gg
CompletedNCT00556036Updated Sep 2, 2020

Hormone Dynamics and Bone Mineral Density in Anorexia Nervosa v. Hypothalamic Amenorrhea

An observational study in Anorexia Nervosa, Hypothalamic Amenorrhea and Obesity, sponsored by Massachusetts General Hospital. Completed at 1 site in United States. Open to female participants aged 18 Years to 45 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2020-09-02.

Sponsored by Massachusetts General Hospital · Observational

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Case-control
Time perspective
Cross-sectional
Enrollment
61
Ages
18 Years to 45 Years
Sex
Female
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 16 studies in Anorexia Nervosa by Massachusetts General Hospital — 2 open to participants now, 2 under way, none of them phase 3. Anorexia Nervosa · Massachusetts General Hospital.

Started
2006
with 1 other
Observational
Only one
of the 16
Registered
5th of 16
by date

Among the 16 studies in Anorexia Nervosa by Massachusetts General Hospital, this one is one of 2 that started in 2006, is the only observational one, and was the 5th registered.

Anorexia Nervosa

471 studies on the registry are indexed under Anorexia Nervosa; 127 are open to participants now.

Browse Anorexia Nervosa studies →

Open to participants now

2 of the 16 studies in Anorexia Nervosa by Massachusetts General Hospital are open now, in 1 country. Recruiting first, the newest first:

By country, each count listing its studies:

All 2 open studies →

Where they have run

Who these studies take

Of the 82 Anorexia Nervosa studies recruiting now, 18 (22%) set no upper age limit and 60 (73%) stop at 75 or younger; 48 take children under 18; 26 take healthy volunteers.

This study: 18 Years to 45 Years · female · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 16 studies in Anorexia Nervosa by Massachusetts General Hospital, or all of them as a file.
02

Study summary

The purpose of this study is to determine whether the hormone dynamics in women with anorexia nervosa and hypothalamic amenorrhea is related to bone loss in those populations.

03

Conditions studied

  • Anorexia Nervosa
  • Hypothalamic Amenorrhea
  • Obesity

Keywords

  • healthy
  • overweight
  • obese
  • anorexia nervosa
  • weight
  • cortisol
  • hormone
  • bone density
  • bone
  • osteopenia
  • osteoporosis
  • amenorrhea
  • menses
  • irregular
  • stress
  • depression
  • exercise
  • diet
04

Who can participate

Ages eligible
18 Years to 45 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

community sample and referrals by specialists

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Amenorrhea for at least three months (unless participating as healthy control)
  • Normal TSH or free thyroxine (free T4).

Exclusion criteria

Exclusion Criteria:

  • A condition known to affect bone metabolism, including Cushing's syndrome or renal failure, with the exception of bone fracture.
  • Any medication known to affect bone metabolism within 3 months of the study, including estrogen and progestins. Patients receiving depot medroxyprogesterone (Depo-Provera) will be excluded from participating for 6 months after their last injection.
  • Pregnant and/or breastfeeding.
  • Diabetes mellitus.
  • Active substance abuse, including alcohol.
05

Study design

Observational model
Case-control
Time perspective
Cross-sectional
Enrollment
61 participants (actual)
Biospecimen retention
Samples without dna

Groups and cohorts

  • 1

    lean healthy women, age 18-45

  • 2

    overweight healthy women, age 18-45

  • 3

    women with hypothalamic amenorrhea (have not had a period in three months), age 18-45

  • 4

    women with anorexia nervosa, age 18-45

06

Study locations

1 site
  • Massachusetts General Hospital
    Boston, Massachusetts 02114, United States
07

Timeline

Tracking since Sep 25, 2026
Not marked actual or estimatedDates not marked actual or estimated

The record gives a start of Mar 2006, a primary completion of Mar 2009 and a completion of Mar 2009. It does not say whether these dates are actual or estimated.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 7, 2007
First posted
Nov 9, 2007
Start
Mar 2006
Primary completionActual
Mar 2009
CompletionActual
Mar 2009
Last update
Sep 2, 2020
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 2, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
08

Registry details

Key details

Study ID
NCT00556036
Collaborators
National Institutes of Health (NIH), Bioenvision
Responsible party
Karen Klahr Miller, MD (Chief, Neuroendocrine Unit, Massachusetts General Hospital) — Principal investigator
First posted
Nov 9, 2007
Start date
Mar 2006
Primary completion
Mar 2009
Completion
Mar 2009
Last update
Sep 2, 2020

Study contacts

Anne A Klibanski, MD
principal investigator · Massachusetts General Hospital
Karen K Miller, MD
study director · Massachusetts General Hospital
Erinne M Meenaghan, NP
study chair · Massachusetts General Hospital
Elizabeth A Lawson, MD
study director · Massachusetts General Hospital
David B Herzog, MD
study chair · Massachusetts General Hospital

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion